Listed

LifeMD, Inc.: Form 10-Q for the period ended Sep 30, 2020

Filed with the SEC on Nov 16, 2020 and accepted by EDGAR at Nov 16, 2020, 16:59 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-07-01 to 2020-09-30$11.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2020-01-01 to 2020-09-30$24.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-07-01 to 2020-09-30$2.7mus-gaap:CostOfRevenue
Cost of revenue9 months2020-01-01 to 2020-09-30$6.7mus-gaap:CostOfRevenue
Gross profit3 months2020-07-01 to 2020-09-30$8.3mus-gaap:GrossProfit
Gross profit9 months2020-01-01 to 2020-09-30$17.7mus-gaap:GrossProfit
Operating income3 months2020-07-01 to 2020-09-30−$20.5mus-gaap:OperatingIncomeLoss
Operating income9 months2020-01-01 to 2020-09-30−$25.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-07-01 to 2020-09-30$291.1kus-gaap:InterestExpense
Interest expense9 months2020-01-01 to 2020-09-30$1.3mus-gaap:InterestExpense
Net income3 months2020-07-01 to 2020-09-30−$20.6mus-gaap:NetIncomeLoss
Net income9 months2020-01-01 to 2020-09-30−$26.4mus-gaap:NetIncomeLoss
Diluted shares (weighted)3 months2020-07-01 to 2020-09-3014,674,693 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2020-01-01 to 2020-09-3012,581,401 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2020-01-01 to 2020-09-30−$5.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2020-09-30$916.6kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-09-30$4.7mus-gaap:AssetsCurrent
Total assetsAt period end2020-09-30$5.4mus-gaap:Assets
Current liabilitiesAt period end2020-09-30$9.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-09-30$13.4mus-gaap:Liabilities
Shareholders' equityAt period end2020-09-30−$7.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-20-021737. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.